Industry reports
Editor highlights

Publication dates

Chemotherapy Research Reports, April 2014

You might be interested in: flow cytometry, hematology, cancer, more »


 

1-10 of 79 reports for Chemotherapy
MidCentral District Health Board SWOT Analysis, Strategy, Revenues and Profits

MidCentral District Health Board SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... To coast, cardiology, cardiology unit, cervical screening, chemotherapy, and child and youth health services. Mdhb also offers child health, children's ward, dannevirke health service, dental health ...

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

... Patient population suffering from xerostomia and radiation dermatitis. These products provide relief to cancer patients undergoing radiation therapy or chemotherapy and patients suffering from sjogren ...

Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

... Acetate for asymptomatic or mildly symptomatic chemotherapy-naive patients with bone predominant metastatic castration-resistant prostate cancer 37jan 30, 2014: progenics pharmaceuticals presents ...

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • April 2014
  • by GBI Research

... Pancreatitis and other medical conditions 132.4.3 Obesity 132.4.4 Infections 132.5 Diagnosis 132.6 Treatment algorithm 142.6.1 Surgery 142.6.2 Radiation therapy 142.6.3 chemotherapy ...

Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

... Infusion pumps & accessories market by product (volumetric, syringe, enteral, insulin, implantable, pca pump), application (diabetes, chemotherapy, nutrition, pain management) & by end-user (hospital ...

World Therapy: Chemotherapy Induced Anemia – Pipeline Review, H1 2012

World Therapy: Chemotherapy Induced Anemia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

... To buy - identify and understand important and diverse types of therapeutics under development for chemotherapy induced anemia.- Identify emerging players with potentially strong product ...

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on chemotherapy induced pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review

Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2014
  • by Global Data

... Is being developed to prevent chemotherapy-induced nausea and vomiting, or emesis in the treatment of cancer patients. Other development programs include expansion of the labeled indication for sustol ...

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Briefing pertaining to the number of trials for the key drugs for treating chemotherapy induced peripheral neuropathy. This report is built using data and information sourced from proprietary databases ...

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Information and data relating to the clinical trials on chemotherapy induced neutropenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.